share_log

Avenue Therapeutics | DEF 14A: Definitive information statements

Avenue Therapeutics | DEF 14A: Definitive information statements

Avenue Therapeutics | DEF 14A：股东委托书决议
美股sec公告 ·  05/06 12:47
Moomoo AI 已提取核心信息
Avenue Therapeutics, Inc. (Avenue) has announced the upcoming Annual Meeting of Stockholders to be held virtually on June 24, 2024. Stockholders are invited to attend the meeting online, where they will vote on several key proposals, including the election of six directors, the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2024, and the approval of an amendment to the Avenue Therapeutics Inc. 2015 Incentive Plan. The amendment proposes an increase in the number of authorized shares issuable under the plan by 5,000,000 shares, extending the plan's term to June 24, 2034, and increasing the annual share limit for awards to non-employee directors. The meeting will also address any other business that may properly come before the...Show More
Avenue Therapeutics, Inc. (Avenue) has announced the upcoming Annual Meeting of Stockholders to be held virtually on June 24, 2024. Stockholders are invited to attend the meeting online, where they will vote on several key proposals, including the election of six directors, the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2024, and the approval of an amendment to the Avenue Therapeutics Inc. 2015 Incentive Plan. The amendment proposes an increase in the number of authorized shares issuable under the plan by 5,000,000 shares, extending the plan's term to June 24, 2034, and increasing the annual share limit for awards to non-employee directors. The meeting will also address any other business that may properly come before the Annual Meeting or any postponement or adjournment thereof. Stockholders of record as of April 30, 2024, are entitled to vote at the meeting. The company emphasizes the importance of stockholder votes and provides various methods for voting, including online and by mobile device. The meeting will also be an opportunity for stockholders to ask questions.
Avenue Therapeutics, Inc.（Avenue）宣布即将于2024年6月24日虚拟举行年度股东大会。邀请股东参加在线会议，他们将对几项关键提案进行投票，包括选举六名董事，批准毕马威会计师事务所作为截至2024年12月31日的年度独立注册会计师事务所，以及批准Avenue Therapeutics Inc. 2015激励计划的修正案。该修正案提议将根据该计划可发行的授权股票数量增加5,000,000股，将该计划的期限延长至2034年6月24日，并提高向非雇员董事发放奖励的年度股份上限。会议还将讨论可能在年会或任何延期或休会之前适当处理的任何其他事项。截至2024年4月30日的登记股东有权在会议上投票。该公司强调股东投票的重要性，并提供各种投票方式，包括在线和移动设备。这次会议也将是股东提问的机会。
Avenue Therapeutics, Inc.（Avenue）宣布即将于2024年6月24日虚拟举行年度股东大会。邀请股东参加在线会议，他们将对几项关键提案进行投票，包括选举六名董事，批准毕马威会计师事务所作为截至2024年12月31日的年度独立注册会计师事务所，以及批准Avenue Therapeutics Inc. 2015激励计划的修正案。该修正案提议将根据该计划可发行的授权股票数量增加5,000,000股，将该计划的期限延长至2034年6月24日，并提高向非雇员董事发放奖励的年度股份上限。会议还将讨论可能在年会或任何延期或休会之前适当处理的任何其他事项。截至2024年4月30日的登记股东有权在会议上投票。该公司强调股东投票的重要性，并提供各种投票方式，包括在线和移动设备。这次会议也将是股东提问的机会。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息